What problem does neuroClues aim to solve for clinicians?
neuroClues aims to solve the challenge of subjective neurological assessments by providing objective, reproducible, and quantified eye movement biomarkers to aid in the diagnosis and monitoring of neurological diseases. This allows clinicians to make appropriate treatment decisions and continuously adapt care to each patient.
In what clinical situations is neuroClues used?
neuroClues is used for neurological assessment to support the diagnosis and monitoring of neurological disorders, perform preventive screening in at-risk populations, and assist in the differential diagnosis of parkinsonian syndromes, particularly distinguishing atypical forms at an early stage.
Who is the primary target user for the neuroClues platform?
The primary target users are neurologists and clinical practices in hospitals. The platform is trusted by neurologists and leading hospitals across Europe for evaluating brain function.
What key features or capabilities does the neuroClues platform offer?
neuroClues offers a portable and high-precision eye movement recording platform designed for clinical practice. It includes objective and quantifiable biomarker data, acquisition in a few minutes that can be delegated, and a procedure that is covered under a reimbursement code.
How is the neuroClues procedure priced or covered?
The eye movement recording procedure performed with neuroClues is a reimbursed procedure, meaning it is covered under a specific reimbursement code.
What types of search queries might lead users to find neuroClues?
Based on its product tags, users might search for terms related to cognitive science, medical devices, diagnostic tools, eye tracking, and biomarkers for patient monitoring.
How does neuroClues' category compare in terms of the number of competing products?
The 'Business Specialist' category, which includes neuroClues, contains 3,151 products according to the measured data.
What is neuroClues?
neuroClues is an eye movement recording platform that uses proprietary AI algorithms to quantify clinical neurological exams, providing objective biomarkers for diagnosing and monitoring neurological disorders.